Total Holdings
64
Portfolio diversification across 64 positions
BBP
(NYSEARCA)Virtus LifeSci Biotech Products ETF
$83.70-- (--)
Loading... - Market loading
BBP ETF Holdings: Virtus LifeSci Biotech Products ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$50.55M
Total fund assets
Expense Ratio
0.34%
Annual management fee
Fund Issuer
Virtus Investment Partners
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | N NK | NantKwest Inc | Stock | 6.06% |
| 2 |  | ImmunityBio, Inc. | Stock | 4.68% |
| 3 |  | Day One Biopharmaceuticals, Inc. | Stock | 3.96% |
| 4 |  | Moderna, Inc. | Stock | 2.63% |
| 5 |  | Iovance Biotherapeutics, Inc | Stock | 2.58% |
| 6 |  | Novavax, Inc | Stock | 2.55% |
| 7 |  | Apellis Pharmaceuticals, Inc. | Stock | 2.48% |
| 8 |  | Mirum Pharmaceuticals, Inc. | Stock | 2.25% |
| 9 |  | Amicus Therapeutics, Inc | Stock | 2.03% |
| 10 |  | Roivant Sciences Ltd. | Stock | 1.95% |
| 11 |  | Agios Pharmaceuticals, Inc. | Stock | 1.94% |
| 12 |  | BioCryst Pharmaceuticals, Inc. | Stock | 1.92% |
| 13 |  | Geron Corporation | Stock | 1.89% |
| 14 |  | KalVista Pharmaceuticals, Inc. | Stock | 1.81% |
| 15 |  | Syndax Pharmaceuticals, Inc. | Stock | 1.81% |
| 16 |  | Gilead Sciences, Inc. | Stock | 1.80% |
| 17 |  | Kiniksa Pharmaceuticals International, plc | Stock | 1.79% |
| 18 |  | Axsome Therapeutics, Inc. | Stock | 1.79% |
| 19 |  | Amgen Inc | Stock | 1.79% |
| 20 |  | United Therapeutics Corporation | Stock | 1.78% |
| 21 |  | Zai Lab Limited | Stock | 1.77% |
| 22 |  | BioNTech SE | Stock | 1.72% |
| 23 |  | BioMarin Pharmaceutical Inc | Stock | 1.72% |
| 24 |  | Krystal Biotech, Inc | Stock | 1.69% |
| 25 |  | Exelixis, Inc. | Stock | 1.67% |
| 26 |  | Halozyme Therapeutics, Inc | Stock | 1.67% |
| 27 |  | TG Therapeutics, Inc. | Stock | 1.66% |
| 28 |  | CRISPR Therapeutics AG | Stock | 1.63% |
| 29 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.63% |
| 30 |  | Biogen Inc. | Stock | 1.63% |
| 31 |  | Ardelyx, Inc | Stock | 1.60% |
| 32 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.59% |
| 33 |  | Incyte Corporation | Stock | 1.57% |
| 34 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.56% |
| 35 |  | Ascendis Pharma AS | Stock | 1.56% |
| 36 | B BGNE | BeiGene, Ltd | Stock | 1.51% |
| 37 |  | Theravance Biopharma Inc | Stock | 1.50% |
| 38 |  | Ionis Pharmaceuticals, Inc | Stock | 1.49% |
| 39 |  | Arcutis Biotherapeutics, Inc | Stock | 1.47% |
| 40 |  | Tarsus Pharmaceuticals Inc | Stock | 1.40% |
| 41 |  | Phathom Pharmaceuticals, Inc | Stock | 1.39% |
| 42 |  | ACADIA Pharmaceuticals Inc | Stock | 1.36% |
| 43 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.35% |
| 44 |  | PTC Therapeutics, Inc | Stock | 1.35% |
| 45 |  | BridgeBio Pharma, Inc | Stock | 1.35% |
| 46 |  | Esperion Therapeutics, Inc | Stock | 1.31% |
| 47 |  | Immunocore Holdings plc | Stock | 1.30% |
| 48 |  | Crinetics Pharmaceuticals Inc | Stock | 1.30% |
| 49 |  | Legend Biotech Corporation | Stock | 1.29% |
| 50 |  | Rhythm Pharmaceuticals, Inc | Stock | 1.29% |
Frequently Asked Questions About Virtus LifeSci Biotech Products ETF Holdings
What are the top holdings in BBP?
Virtus LifeSci Biotech Products ETF (BBP) holds 64 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BBP's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BBP's holdings table to analyze concentration risk.
What is BBP's sector allocation?
The Sector Allocation chart shows how BBP distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BBP invest in?
BBP's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BBP ETF?
BBP's diversification can be assessed by reviewing its 64 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.